Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 27%
Buy 47%
Hold 20%
Sell 0%
Strong Sell 7%

Bulls say

Intuitive Surgical demonstrates a robust growth trajectory, evidenced by approximately 13% year-over-year procedure growth, which was further bolstered by a 90 basis point increase predominantly in the U.S. market. The company reported an 11% rise in Ion utilization alongside a notable 21% growth in SP system utilization, supporting an expanding installed base of 995 and 377 systems, respectively, indicating increasing adoption and operational efficiency. Additionally, a slight increase in system average selling prices (ASPs) reflects the favorable market dynamics and demand for its advanced surgical solutions.

Bears say

The analysis reveals concerns regarding Intuitive Surgical's projected revenue growth, particularly with the downward pressure on average selling prices (ASPs) and a slower-than-expected adoption of the da Vinci system, notably the Dv5 model. Despite achieving growth in specific procedure areas such as benign general surgery, the overall revenue trajectory for instruments and accessories remains less reliant on the new system's adoption, indicating a potential weakness in sustaining revenue growth. Additionally, broader market challenges, such as a tough capital purchasing environment and increasing competition, further cast doubts on the company's ability to maintain its historical growth rates, suggesting caution for investors.

Intuitive Surgical (ISRG) has been analyzed by 15 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 47% recommend Buy, 20% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 15 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $615.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $615.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.